<em>Diospyros lotus</em> leaf extract and its main component, myricitrin, inhibit both histamine‑dependent and histamine‑independent itching

Shin,Jae Young; Kim,Bo Mi; Jang,Seon Il

doi:10.3892/etm.2025.12871

Diospyros lotus leaf extract and its main component, myricitrin, inhibit both histamine‑dependent and histamine‑independent itching

Authors:
- Jae Young Shin
- Bo Mi Kim
- Seon Il Jang
View Affiliations

Affiliations: Institute of Health and Science, Jeonju University, Jeonju, Jeonbuk 55069, Republic of Korea, Department of Chemical Engineering, Wonkwang University, Iksan, Jeonbuk 54538, Republic of Korea
Published online on: April 16, 2025 https://doi.org/10.3892/etm.2025.12871
Article Number: 121
Copyright: © Shin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pruritus is a distressing symptom associated with various dermatological, systemic and neurological conditions, markedly impairing quality of life. Pruritus arises through histamine‑dependent and histamine‑independent pathways, involving mediators such as histamine, gastrin‑releasing peptide (GRP), interleukin‑31 (IL‑31) and STAT3 signaling. The present study aimed to investigate the antipruritic effects of Diospyros lotus leaf extract (DLE) and its major constituent, myricitrin (MC), on ICR mice using compound 48/80 (histamine‑dependent) and chloroquine (histamine‑independent) itch models. Serum levels of histamine and IL‑31 were measured by ELISA, and mast cell infiltration was assessed via toluidine blue staining. Furthermore, the expression and activation of GRP receptor (GRPR), IL‑31RA and STAT3 in the spinal cord were analyzed using western blotting and immunofluorescence staining. Notably, DLE and MC significantly reduced scratching behavior, serum histamine levels and mast cell infiltration in both models. Immunofluorescence staining and western blot analysis revealed that DLE and MC downregulated GRPR, IL‑31 receptor A and phosphorylated STAT3 expression in the spinal cord, indicating modulation of central itch signaling. Additionally, DLE and MC suppressed IL‑31 levels in serum and skin tissues. These findings indicated that DLE and MC may alleviate pruritus through multiple mechanisms, including mast cell stabilization, histamine reduction and modulation of central itch pathways. The broad‑spectrum antipruritic activity of DLE and MC highlights their potential as natural therapeutic agents for diverse pruritic conditions, offering a safer alternative to synthetic antipruritic drugs. Further research is warranted to validate these findings in clinical settings and to elucidate the molecular mechanisms underlying their efficacy.

View Figures

View References

1	Bourane S, Duan B, Koch SC, Dalet A, Britz O, Garcia-Campmany L, Kim E, Cheng L, Ghosh A, Ma Q and Goulding M: Gate control of mechanical itch by a subpopulation of spinal cord interneurons. Science. 350:550–554. 2015.PubMed/NCBI View Article : Google Scholar
2	Krajnik M and Zylicz Z: Understanding pruritus in systemic disease. J Pain Symptom Manage. 21:151–168. 2001.PubMed/NCBI View Article : Google Scholar
3	Ständer S, Zeidler C, Magnolo N, Raap U, Mettang T, Kremer AE, Weisshaar E and Augustin M: Clinical management of pruritus. J Dtsch Dermatol Ges. 13:101–116. 2015.PubMed/NCBI View Article : Google Scholar : (In English, German).
4	Lyell A: The itching patient. A review of the causes of pruritus. Scott Med J. 17:334–347. 1972.PubMed/NCBI View Article : Google Scholar
5	Song J, Xian D, Yang L, Xiong X, Lai R and Zhong J: Pruritus: Progress toward pathogenesis and treatment. Biomed Res Int. 2018(9625936)2018.PubMed/NCBI View Article : Google Scholar
6	Wang F, Yang TLB and Kim BS: The return of the mast cell: New roles in neuroimmune itch biology. J Invest Dermatol. 140:945–951. 2020.PubMed/NCBI View Article : Google Scholar
7	Amin K: The role of mast cells in allergic inflammation. Respir Med. 106:9–14. 2012.PubMed/NCBI View Article : Google Scholar
8	Haugen HF and Skrede S: Nucleotide pyrophosphatase and phosphodiesterase I. Demonstration of activity in normal serum, and an increase in cholestatic liver disease. Scand J Gastroenterol. 11:121–127. 1976.PubMed/NCBI
9	Sugimoto Y, Umakoshi K, Nojiri N and Kamei C: Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur J Pharmacol. 351:1–5. 1998.PubMed/NCBI View Article : Google Scholar
10	Mießner H, Seidel J and Smith ESJ: In vitro models for investigating itch. Front Mol Neurosci. 15(984126)2022.PubMed/NCBI View Article : Google Scholar
11	Yosipovitch G, Rosen JD and Hashimoto T: Itch: From mechanism to (novel) therapeutic approaches. J Allergy Clin Immunol. 142:1375–1390. 2018.PubMed/NCBI View Article : Google Scholar
12	Ma Q: Labeled lines meet and talk: Population coding of somatic sensations. J Clin Invest. 120:3773–3778. 2010.PubMed/NCBI View Article : Google Scholar
13	Mishra SK and Hoon MA: Transmission of pruriceptive signals. In: Pharmacology of Itch. Cowan A and Yosipovitch G (eds) Vol 226. Springer Berlin Heidelberg, Berlin, Heidelberg, pp151-162, 2015.
14	Sun YG and Chen ZF: A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 448:700–703. 2007.PubMed/NCBI View Article : Google Scholar
15	Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, et al: Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell. 139:1353–1365. 2009.PubMed/NCBI View Article : Google Scholar
16	Mnyika KS and Kihamia CM: Chloroquine-induced pruritus: Its impact on chloroquine utilization in malaria control in Dar es Salaam. J Trop Med Hyg. 94:27–31. 1991.PubMed/NCBI
17	Rauf A, Uddin G, Patel S, Khan A, Halim SA, Bawazeer S, Ahmad K, Muhammad N and Mubarak MS: Diospyros, an under-utilized, multi-purpose plant genus: A review. Biomed Pharmacother. 91:714–730. 2017.PubMed/NCBI View Article : Google Scholar
18	Cho BO, Yin HH, Fang CZ, Kim SJ, Jeong SI and Jang SI: Hepatoprotective effect of Diospyros lotus leaf extract against acetaminophen-induced acute liver injury in mice. Food Sci Biotechnol. 24:2205–2212. 2015.
19	Kim BM, Cho BO and Jang SI: Anti-obesity effects of Diospyros lotus leaf extract in mice with high-fat diet-induced obesity. Int J Mol Med. 43:603–613. 2019.PubMed/NCBI View Article : Google Scholar
20	Cho BO, Che DN, Shin JY, Kang HJ, Kim JH, Kim HY, Cho WG and Jang SI: Ameliorative effects of Diospyros lotus leaf extract against UVB-induced skin damage in BALB/c mice. Biomed Pharmacother. 95:264–274. 2017.PubMed/NCBI View Article : Google Scholar
21	Cho BO, Che DN, Yin HH, Shin JY and Jang SI: Diospyros lotus leaf and grapefruit stem extract synergistically ameliorate atopic dermatitis-like skin lesion in mice by suppressing infiltration of mast cells in skin lesions. Biomed Pharmacother. 89:819–826. 2017.PubMed/NCBI View Article : Google Scholar
22	Shin JY, Cho BO, Park JH, Kang ES, Kim YS and Jang SI: Diospyros lotus leaf extract and its main component myricitrin regulate pruritus through the inhibition of astrocyte activation. Exp Ther Med. 26(323)2023.PubMed/NCBI View Article : Google Scholar
23	Kwiatkowska D and Reich A: Role of mast cells in the pathogenesis of pruritus in mastocytosis. Acta Derm Venereol. 101(adv00583)2021.PubMed/NCBI View Article : Google Scholar
24	Barry DM, Liu XT, Liu B, Liu XY, Gao F, Zeng X, Liu J, Yang Q, Wilhelm S, Yin J, et al: Exploration of sensory and spinal neurons expressing gastrin-releasing peptide in itch and pain related behaviors. Nat Commun. 11(1397)2020.PubMed/NCBI View Article : Google Scholar
25	Datsi A, Steinhoff M, Ahmad F, Alam M and Buddenkotte J: Interleukin-31: The ‘itchy’ cytokine in inflammation and therapy. Allergy. 76:2982–2997. 2021.PubMed/NCBI View Article : Google Scholar
26	Shiratori-Hayashi M, Yamaguchi C, Eguchi K, Shiraishi Y, Kohno K, Mikoshiba K, Inoue K, Nishida M and Tsuda M: Astrocytic STAT₃ activation and chronic itch require IP3R1/TRPC-dependent Ca²⁺ signals in mice. J Allergy Clin Immunol. 147:1341–1353. 2021.PubMed/NCBI View Article : Google Scholar
27	Steinhoff M, Ahmad F, Pandey A, Datsi A, AlHammadi A, Al-Khawaga S, Al-Malki A, Meng J, Alam M and Buddenkotte J: Neuroimmune communication regulating pruritus in atopic dermatitis. J Allergy Clin Immunol. 149:1875–1898. 2022.PubMed/NCBI View Article : Google Scholar
28	Di Salvo E, Gangemi S, Genovese C, Cicero N and Casciaro M: Polyphenols from mediterranean plants: Biological activities for skin photoprotection in atopic dermatitis, psoriasis, and chronic urticaria. Plants (Basel). 12(3579)2023.PubMed/NCBI View Article : Google Scholar
29	Kaag S and Lorentz A: Effects of dietary components on mast cells: Possible use as nutraceuticals for allergies? Cells. 12(2602)2023.PubMed/NCBI View Article : Google Scholar
30	Perrelli A, Goitre L, Salzano AM, Moglia A, Scaloni A and Retta SF: Biological activities, health benefits, and therapeutic properties of avenanthramides: from skin protection to prevention and treatment of cerebrovascular diseases. Oxid Med Cell Longev. 2018(6015351)2018.PubMed/NCBI View Article : Google Scholar
31	Mwakalukwa R, Ashour A, Amen Y, Niwa Y, Tamrakar S, Miyamoto T and Shimizu K: Anti-allergic activity of polyphenolic compounds isolated from olive mill wastes. J Funct Foods. 58:207–217. 2019.
32	Ortiz-Cerda T, Argüelles-Arias F, Macías-García L, Vázquez-Román V, Tapia G, Xie K, García-García MD, Merinero M, García-Montes JM, Alcudia A, et al: Effects of polyphenolic maqui (Aristotelia chilensis) extract on the inhibition of NLRP3 inflammasome and activation of mast cells in a mouse model of Crohn's disease-like colitis. Front Immunol. 14(1229767)2024.PubMed/NCBI View Article : Google Scholar
33	Shaik Y, Caraffa A, Ronconi G, Lessiani G and Conti P: Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin. Cent Eur J Immunol. 43:476–481. 2018.PubMed/NCBI View Article : Google Scholar
34	Vo TS, Le TT, Kim S and Ngo D: The role of myricetin from Rhodomyrtus tomentosa (Aiton) Hassk fruits on downregulation of FcɛRI-mediated mast cell activation. J Food Biochem. 44(e13143)2020.PubMed/NCBI View Article : Google Scholar
35	Trier AM and Kim BS: Cytokine modulation of atopic itch. Curr Opin Immunol. 54:7–12. 2018.PubMed/NCBI View Article : Google Scholar
36	Shin JY, Cho BO, Park JH, Kang ES, Kim JH, Ha HY, Kim YS and Jang SI: Diospyros lotus leaf extract and its main component myricitrin inhibit itch-related IL-6 and IL-31 by suppressing microglial inflammation and microglial-mediated astrocyte activation. Mol Med Rep. 30(178)2024.PubMed/NCBI View Article : Google Scholar
37	Tsuda M: Spinal dorsal horn astrocytes: New players in chronic itch. Allergol Int. 66:31–35. 2017.PubMed/NCBI View Article : Google Scholar
38	Aziz MdA, Sarwar MdS, Akter T, Uddin MS, Xun S, Zhu Y, Islam MS and Hongjie Z: Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer. Life Sci. 268(118999)2021.PubMed/NCBI View Article : Google Scholar
39	Yin Q, Wang L, Yu H, Chen D, Zhu W and Sun C: Pharmacological effects of polyphenol phytochemicals on the JAK-STAT signaling pathway. Front Pharmacol. 12(716672)2021.PubMed/NCBI View Article : Google Scholar